{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Be+Specific&page=48", "query": { "intervention": "Be Specific", "page": 48 }, "page_size": 10 }, "pagination": { "page": 48, "page_size": 10, "total_count": 4639, "total_pages": 464, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Be+Specific&page=49&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Be+Specific&page=47&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T03:38:36.670Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03286699", "title": "Lifestyle Change for Better Health", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bladder Cancer", "Telomere Shortening", "Colorectal Adenoma" ], "interventions": [ { "name": "Dietary Intervention", "type": "BEHAVIORAL" }, { "name": "Physical Activity Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 8, "start_date": "2017-06-01", "completion_date": "2024-10-01", "has_results": false, "last_update_posted_date": "2025-01-10", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03286699" }, { "nct_id": "NCT05823532", "title": "Anti-Inflammatory Challenge in Schizophrenia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Infliximab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 60, "start_date": "2024-04-18", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05823532" }, { "nct_id": "NCT04544709", "title": "Intradiscal Platelet Rich Plasma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Discogenic Pain", "Low Back Pain", "Chronic Pain" ], "interventions": [ { "name": "Low back intradiscal injection of platelet rich plasma (PRP)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2019-02-14", "completion_date": "2022-07-29", "has_results": true, "last_update_posted_date": "2023-12-11", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04544709" }, { "nct_id": "NCT06015490", "title": "The Impact of the Physiological Response to Sugar on Brain Activity and Behavior", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Food Preferences", "Appetitive Behavior" ], "interventions": [ { "name": "Sucrose drink", "type": "OTHER" }, { "name": "Glucose drink", "type": "OTHER" }, { "name": "Fructose drink", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Virginia Polytechnic Institute and State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 7, "start_date": "2023-09-01", "completion_date": "2024-07-22", "has_results": true, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 1, "location_summary": "Roanoke, Virginia", "locations": [ { "city": "Roanoke", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06015490" }, { "nct_id": "NCT03193190", "title": "A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Nab-Paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Fluorouracil", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Cobimetinib", "type": "DRUG" }, { "name": "PEGPH20", "type": "DRUG" }, { "name": "BL-8040", "type": "DRUG" }, { "name": "Selicrelumab", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "RO6874281", "type": "DRUG" }, { "name": "AB928", "type": "DRUG" }, { "name": "Tiragolumab", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 341, "start_date": "2017-07-05", "completion_date": "2025-02-27", "has_results": true, "last_update_posted_date": "2025-11-21", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 12, "location_summary": "Duarte, California • San Francisco, California • New Haven, Connecticut + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03193190" }, { "nct_id": "NCT06464926", "title": "Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nausea", "Vomiting" ], "interventions": [ { "name": "Enterra Therapy System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Enterra Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 148, "start_date": "2025-06-23", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 12, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Newport Beach, California + 9 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06464926" }, { "nct_id": "NCT02017548", "title": "Default Options in Advance Directives", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "This Study Will Focus on Advance Care Planning Among Patients With Life-limiting Illnesses" ], "interventions": [ { "name": "Life-extension default advance directive", "type": "BEHAVIORAL" }, { "name": "Comfort default advance directive", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 270, "start_date": "2014-01", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2019-04-01", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 4, "location_summary": "Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02017548" }, { "nct_id": "NCT03682055", "title": "Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Nasopharyngeal Carcinoma", "Nasopharyngeal Cancer" ], "interventions": [ { "name": "VK-2019", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cullinan Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2019-04-04", "completion_date": "2020-08-08", "has_results": true, "last_update_posted_date": "2023-08-15", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 2, "location_summary": "Stanford, California • Houston, Texas", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03682055" }, { "nct_id": "NCT06325748", "title": "SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "AML/MDS", "CD33 Expressing Hematological Malignancies", "FLT3 Expressing Hematological Malignancies" ], "interventions": [ { "name": "SENTI-202", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Senti Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 21, "start_date": "2024-04-22", "completion_date": "2040-08", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 6, "location_summary": "Los Angeles, California • Denver, Colorado • Jacksonville, Florida + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06325748" }, { "nct_id": "NCT04660552", "title": "Transcranial Photobiomodulation for Reducing Autism Symptoms in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autism Spectrum Disorder" ], "interventions": [ { "name": "Cognilum TM: Light Treatment Condition", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "JelikaLite LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "2 Years to 6 Years" }, "enrollment_count": 34, "start_date": "2020-11-15", "completion_date": "2023-12-30", "has_results": true, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-10-28T03:38:36.670Z", "location_count": 2, "location_summary": "Brooklyn, New York • New York, New York", "locations": [ { "city": "Brooklyn", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04660552" } ] }